www.brit-thoracic.org.uk/standards-of-care/guidelines/btsguideline-for-emergency-oxygen-use-in-adult-patients/ 
Oxygen -there is a problem
• Doctors and nurses have a poor understanding of how oxygen should be used • Oxygen is often given without a prescription (2015 BTS audit -42% of hospital patients using oxygen had no prescription) • If there is a prescription, patients do not always receive what is specified on the prescription • Where there is a prescription with target range -69% of SpO2 results were within the target range -9.5% below target range -21.5% above target range Learning points for me?
• Up to date with guidance?
• Housekeeping across my areas of clinical responsibility -what does that look like?
Basis of the BTS guideline: Prescribing by target oxygen saturation
Keep the oxygen saturation normal/near-normal for all patients except pre-defined groups who are at risk from hypercapnic respiratory failure
What is the minimum arterial oxygen level recommended in acute illness?
• Target oxygen saturation What is a "normal" nocturnal oxygen saturation?
Healthy subjects in all age groups routinely desaturate to an average nadir of 90.4% during the night (SD 3.1%) Gries RE et al Chest 1996; 110: 1489-92 *Therefore, be cautious in interpreting a single oximetry measurement from a sleeping patient. Watch the oximeter for a few minutes if in any doubt (if the patient is otherwise stable) because normal overnight dips are of short duration.
Normal Range for Oxygen saturation
Normal range for healthy young adults is approximately 96-98% (Crapo AJRCCM, 1999; 160:1525) There is a slight fall with advancing age A study of 871 subjects showed that age > 60 was associated with minor SpO2 reduction of 0.4% (Witting MD et al Am J Emerg Med 2008: 26: 131-136 ) An audit in Salford and Southend showed mean SpO2 of 96.7% with SD 1.9 in 320 stable hospital patients aged >70 without lung disease or heart failure (2 SD range 92.9 to 100%) (O'Driscoll R et al Thorax 2008; 63(suppl 
Nasal Cannulae (N)
• Recommended in the Guideline as suitable for most patients with both type I and II respiratory failure.
• 1-6L/min gives approx 24-50% FIO2 • FIO2 depends on oxygen flow rate and patient's minute volume and inspiratory flow and pattern of breathing.
• Comfortable and easily tolerated • No re-breathing • Low cost product • Preferred by patients (vs simple mask)
Venturi or Fixed Performance Masks (V)
• Aim to deliver constant oxygen concentration within and between breaths.
• 24-40% Venturi Masks operate accurately A 60% Venturi mask gives ~50% FIO2
• With TACHYPNOEA (RR >30/min) the oxygen flow rate should be increased by above the minimum flow rate shown on the packaging -see next slide • Increasing flow does not increase oxygen concentration because it is a fixed dose
Simple face mask (SM) (Medium concentration, variable performance)
• Used for patients with type I respiratory failure.
• Delivers variable O2 concentration between 35% & 60%.
• Low cost product.
• Flow 5-10 L/min
Flow must be at least 5 L/min to avoid CO2 build up and resistance to breathing

Titrating Oxygen up and down
This table below shows APPROXIMATE conversion values.
FLOW CHART FOR OXYGEN ADMINISTRATION ON GENERAL WARDS IN HOSPITALS
• See target saturation in the patient's drug chart. Choose the most suitable delivery system and flow rate • Titrate oxygen up or down to maintain the target oxygen saturation • The table below shows available options for stepping dosage up or down.
• The chart does NOT imply any equivalence of dose between Venturi masks and nasal cannulae.
• Allow at least 5 minutes at each dose before adjusting further upwards or downwards • (except with major and sudden fall in saturation -falls ≥3% also require clinical review) • Once your patient has adequate and stable saturation on minimal oxygen dose, consider discontinuation of oxygen therapy.
Pause and thoughts
High flow nasal oxygen therapy HFNOT therapy is a medical device that delivers gas with a flow rate (up to 60 L/min), warmed to body temperature (34 -37 degrees), pressure saturated for optimal humidification with accurately titrated oxygen content (21-100%) to spontaneously breathing patients.
The device has a compressor system providing the ability to mix room air and piped oxygen. The device has an internal O2 analyser. 
HFNOT is increasingly becoming the mechanism of choice in the management of patients with Type 1 respiratory failure
High flow humidified nasal oxygen (HFNOT)
Proposal 1:
Unconscious dying patients • HFNO therapy is not indicated for symptom management in dying patients. Where the patient is deeply unconscious the delivery device should be switched off and the nasal cannula should be removed.
• Where the patient seems aware at times a prn dose of opioid should be administered in advance of stopping the delivery device.
-1/6 to 1/4 of the total daily opioid dose or -Morphine 5mg SC if opioid naïve or -Oxycodone 2.5 mg if opioid naïve and CKD 4 or 5
• Should the patient become unexpectedly distressed within the first 10 minutes following removal then replace the device (same flow rate and FiO2 Time to talk
• Discuss the balance of benefits of treatment as against the burdens and harms of that treatment -HFNO therapy will delay dying where dying is inevitable -Will need to remain on current ward and will be unable to return home -May develop pressure areas from nasal cannula • Offer your diagnosis that the patient is approaching the end of their life • Offer your view that the patient is no longer benefitting from HFNO therapy • Discuss the other possibilities of managing symptoms using opioids, benzodiazepines, other means of providing air movement and position • Offer the patient time to think and arrange a time to review Discontinuing HFNO therapy:
• Give a prn dose of opioid 20 -30 minutes in advance of stopping the delivery device.
• 1/6 to 1/4 of the total daily opioid dose or • Morphine 5mg SC if opioid naïve or • Oxycodone 2.5 mg if opioid naïve and CKD 4 or 5 -Switch from HFNO therapy to nasal cannula at 4 L/minute and FiO 2 24% -Monitor for 15 minutes -if the patient is comfortable reduce the flow rate to 2 L/minute and discontinue after an hour -Give regular 4 hourly opioid (oral or SC) and if necessary a benzodiazepine -Review the situation at 24 hours and calculate the total opioid dose needed in 24 hours (oral or SC)
Q4
Have you discontinued HFNOT Never Once 2 -5 5 -10 >10
Have you discontinued HFNOT Any comments?
